Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Terminated × Neurofibromatosis 1 × Lamotrigine × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 2 Noonan Syndrome 1 Cognition Disorders 1

Interventions

Magnetic Resonance Imaging 2 Lamotrigine 2 lorlatinib 1 gadolinium compound P760 1 encorafenib 1 cediranib 1 binimetinib 1 Vitamin D 1 Lovastatin 1 Gadolinium DTPA 1 Fluorodeoxyglucose F18 1 Everolimus 1 Dietary Supplements 1 Cholecalciferol 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03504501 2023-11-30

SynCoRAS

Technical University of Munich

Phase 2 Terminated

Cognition Disorders, Neurofibromatosis 1, Noonan Syndrome

NCT02256124 2020-04-14

NF1-EXCEL

Erasmus Medical Center

Phase 2/3 Terminated

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡